Management of Metastatic Spinal Disease

Introduction to Metastatic Spinal Disease

Spinal metastases occur in approximately 70% of cancer patients at autopsy, with breast, lung, and prostate cancers accounting for over 50% of cases, according to the National Comprehensive Cancer Network 1, 2

The spine's predilection for metastatic involvement relates to its rich vascular supply through Batson's venous plexus, which allows hematogenous spread of tumor cells, as stated by the American Cancer Society 1

Pain syndromes, including mechanical instability pain, radicular pain, and neuropathic pain, can occur in patients with metastatic spinal disease, as reported by the Cancer Treatment Reviews 3, 4
Neurological deficits, such as metastatic epidural spinal cord compression (MESCC), can cause cord or cauda equina compression, according to the National Institute of Neurological Disorders and Stroke 1, 5
Skeletal-related events (SREs), including pathological fractures, spinal instability, hypercalcemia, and need for urgent intervention, can occur in patients with metastatic spinal disease, as stated by the Cancer and Metastasis Reviews 4, 2

MRI of the entire spine with contrast (T1 and T2 sequences) is the gold standard for diagnosing metastatic spinal disease, and must be performed according to strict timeframes based on clinical presentation, as recommended by the American College of Radiology 5

Dexamethasone must be administered immediately upon clinical-radiological diagnosis of spinal cord compression, before definitive treatment, according to the National Comprehensive Cancer Network 5
The minimum dose of dexamethasone is 4 mg every 6 hours (16 mg/day), with a range of 10-100 mg based on severity, as stated by the American Cancer Society 5

Surgery requires minimum 3-month life expectancy, adequate performance status, and localized disease amenable to intervention, as recommended by the American Society of Clinical Oncology 3, 5
Radiotherapy is the preferred treatment when adequate dose can be delivered, providing pain relief in 50-58% and complete pain resolution in 30-35% of patients, according to the Cancer Treatment Reviews 3, 5

Bisphosphonates and denosumab reduce skeletal-related events but require significant dose adjustments in ESRD, as stated by the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline 5
Denosumab does not require renal dose adjustment and may be safer in ESRD patients, according to the American Journal of Kidney Diseases 6, 5

Vertebroplasty or kyphoplasty provides rapid pain relief for vertebral compression fractures, with additive effects when combined with radiotherapy, as reported by the Journal of Pain and Symptom Management 5
Rehabilitation and supportive care, including physical therapy, occupational therapy, and pain management, are essential for patients with metastatic spinal disease, according to the National Comprehensive Cancer Network 3

Urgent ad hoc multidisciplinary consultation is mandatory for progressive neurological deficits, as recommended by the American College of Surgeons 5
A designated responsible physician should coordinate all care and serve as primary contact, according to the Institute of Medicine 3

Median survival after spinal surgery for metastases is 8 months, with 49% developing recurrent cord compression, as reported by the Journal of Neurosurgery 5